Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF)

NCT03490994 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Acute Heart Failure

Interventions

DRUG: Rivaroxaban
DRUG: Warfarin + LMWH

Sponsor

Yonsei University